FDA Clearance Tracker · P010047-S028
PROGEL PLEURAL AIR LEAK SEALANT
Last checked: Nov 20, 2026Latest source record: Nov 8, 2013 (this decision)Source: openFDAMethods & limitations
Decided
Nov 8, 2013
Approved
Time to decision
246 days
Received Mar 7, 2013. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P010047-S028
- Device name
- PROGEL PLEURAL AIR LEAK SEALANT
- Applicant
- Neomend, Inc.
- Applicant location
- Irvine, CA
- Received
- Mar 7, 2013
- Decided
- Nov 8, 2013
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol - OSB
- Original approval
- P010047
Device type
- Device type
- Sealant, polymerizing (NBE)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.
Source documents
Other decisions for Neomend, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P150016 · Decided Apr 11, 2016 · 350 days after receipt
Device type: Sealant, polymerizing (NBE) · Cardiology
- PROGEL PLEURAL AIR LEAK SEALANTPMA supplement
P010047-S036 · Decided Feb 13, 2015 · 217 days after receipt · Panel Track
Device type: Sealant, polymerizing (NBE) · Anesthesiology & Respiratory
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.